Mosapride

CAS No. 112885-41-3

Mosapride( TAK-370 | AS-4370 )

Catalog No. M21174 CAS No. 112885-41-3

Mosapride is a selective 5HT4 agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
10MG 42 In Stock
25MG 67 In Stock
50MG 94 In Stock
100MG 137 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mosapride
  • Note
    Research use only, not for human use.
  • Brief Description
    Mosapride is a selective 5HT4 agonist.
  • Description
    Mosapride is a selective 5HT4 agonist.
  • In Vitro
    ——
  • In Vivo
    Animal Model:NSAID-induced experimental ulcer model Dosage:0.25, 0.5 , 0.75 mg/kg Administration:p.o Result:Inhibited the mucosal damage.
  • Synonyms
    TAK-370 | AS-4370
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT
  • Research Area
    Metabolic Disease
  • Indication
    Gastroesophageal Reflux Disease

Chemical Information

  • CAS Number
    112885-41-3
  • Formula Weight
    421.9
  • Molecular Formula
    C21H25ClFN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:84 mg/mL (199.1 mM)
  • SMILES
    CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Odaka T et al. Serotonin 5- HT4 receptor agonist (mosapride citrate). Nihon Rinsho. 2006 Aug;64(8):1491-4.
molnova catalog
related products
  • Olopatadine hydrochl...

    Olopatadine hydrochloride is a histamine blocker used to treat allergic conjunctivitis.

  • AVN-101 hydrochlorid...

    AVN-101 is a very potent 5-HT7 receptor antagonist (Ki = 153 pM). AVN-101 also exhibits a rather high affinity toward histamine H1 (Ki = 0.58 nM) and adrenergic α2A, α2B, and α2C (Ki = 0.41-3.6 nM) receptors.

  • SB-200646

    SB-200646 is a selective and potent?antagonist of 5-HT2B/5-HT2C receptor.